This post was originally published on this site
Wood expects these companies have the potential for ‘disruptive innovation.’ The ETF has gained 86.4% over the past year.
ARKK holds a substantial stake in Zillow Group (NASDAQ:ZG), Inc. (Z) and Fate Therapeutics, Inc. (FATE). As of September 9, ARKK held 6,470,458 shares of Z, representing 2.8% of ARKK’s portfolio, while FATE represented nearly 2% of the portfolio. These two stocks are among ARKK’s top 20 holdings. And, given their sound fundamentals and disruptive growth prospects, Wall Street analysts expect them to rally by 40% in price soon.
